
The Drugs Don’t Work: Addressing the Global Rise of Antimicrobial Resistance
Representative photo · Photo: Jim Smillie / Wikimedia Commons, CC BY-SA 2.0
A new film explores the urgent crisis of antimicrobial resistance, which could claim eight million lives annually by 2050 as antibiotics lose their effectiveness.
The documentary titled The Drugs Don’t Work examines the escalating global health crisis driven by the overuse of antibiotics and the rise of drug-resistant superbugs. As medical professionals struggle to treat infections, the reality of what this means for patients is explored through the lens of infant mortality in sub-Saharan Africa. The film highlights how health workers in developing regions are forced to combat these resistant pathogens using limited, low-tech resources.
Understanding the Drugs Don't Work Crisis
The narrative shifts to the United Kingdom to trace the history of penicillin, the world’s most successful antibiotic, and the subsequent decline in new medical breakthroughs. The film investigates why major pharmaceutical entities, such as GlaxoSmithKline, face significant difficulties in developing novel solutions to address the problem of antimicrobial resistance (AMR). This lack of innovation has left the medical community vulnerable as existing treatments become increasingly ineffective.
Overuse of antibiotics is fueling the rise of superbugs that could kill eight million people annually by 2050.
To bridge the gap in research, the documentary showcases cutting-edge academic work at British universities and hospitals. This effort is bolstered by the technological contributions of DeepMind, a UK-based company applying advanced computing to complex biological problems. Advocates and researchers are featured throughout the film, detailing their lifelong commitment to solving the AMR crisis.
Returning to the front lines in Africa, the film demonstrates how local innovation, combined with tools developed in the West, is beginning to save lives. These collaborative efforts are essential to the global battle against resistant bacteria, offering a path forward that could prevent millions of future deaths.
Why it matters
This crisis represents a fundamental shift in global health, as the tools that have sustained modern medicine for decades are losing their efficacy. The impact is felt most acutely by vulnerable populations, particularly infants in developing nations, who face the highest risk from untreatable infections.
For readers in India and South Asia, this issue is of critical importance given the region's high burden of infectious diseases. The global shift toward addressing AMR through technological innovation and local adaptation is a vital step in ensuring that life-saving treatments remain available for future generations.
Sources
More like this

Experts say trusted messengers are critical as Amish grapple with measles outbreak

Children in Gaza Struggle to Access Life-Saving Insulin Amid Ongoing Conflict

Man rescued from house fire in Rochdale hospitalised

